Helix BioPharma (TSE:HBP) has released an update.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Helix BioPharma Corp. has appointed James B. Murphy as its new Chief Financial Officer, bringing his extensive experience in finance and operations management to the company. Murphy, a seasoned consultant in the life sciences industry, is expected to drive strategic growth and support Helix’s focus on advancing its CEACAM6 platform in oncology.
For further insights into TSE:HBP stock, check out TipRanks’ Stock Analysis page.